Testicular Lesions: Improving Characterization
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Causes, Screening and Diagnosis".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 125
Special Issue Editor
2. Faculté de Médecine, Université Paris Saclay, 94270 Le Kremlin-Bicêtre, France
3. BIOMAPS, IR4M, UMR8081, 91401 Orsay Cedex, France
Interests: male reproductive system imaging
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Testicular cancer is the most common malignancy to affect men between the ages of 15 and 49. It is usually suspected in the presence of a swollen testis revealing a palpable intratesticular mass. Scrotal ultrasound confirms the intratesticular tumor, leading the patient to surgery. Ultrasound and its advanced applications play an important role in the characterization of the tumor because percutaneous biopsy is still not allowed as a pre-operative procedure to confirm the malignant process.
In many cases, tumoral blood markers are normal. Imaging including body-computed tomography helps in staging and follow-up, and PET CT aids in the evaluation after chemotherapy for seminomatous germ cell tumors. Some innovations are emerging, like the incidental discovery of undetermined nodules at US, especially during infertility screening. Imaging characterization should be accurate in order to avoid inappropriate management such as orchiectomy for a benign lesion, or no follow-up or surgery for a missed unusual tumoral process.
We recently published a Special Issue, including nine manuscripts authored by experts in the field, highlighting the role of conventional US and advances in imaging techniques such as elastography, contrast-enhanced ultrasound, and multiparametric MRI. We also described the role of body imaging in the extension screening and follow-up, including CT and PET CT.
In this new Special Issue, we aim to highlight further studies including the role of MRI and other advanced techniques. We would like also to explore rare tumors, and pseudo-tumoral findings.
Prof. Dr. Laurence Rocher
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- testicular tumor imaging
- ultrasound
- color
- Doppler
- elastography
- computed tomography
- testicular MRI
- contrast-enhanced sonography
